AtriCure Reports First Patient Has Been Treated With The Revolutionary AtriClip FLEX-Mini Device
AtriCure Reports First Patient Has Been Treated With The Revolutionary AtriClip FLEX-Mini Device
AtriCure, Inc. ((ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the first patient was treated with the AtriClip FLEX-Mini device, which recently received 510(k) clearance. The AtriClip FLEX-Mini sets a new standard as the smallest profile surgical LAA device on the market and builds upon the proven technology of AtriCure's AtriClip platform, with ease of use and design simplicity that offers enhanced access and increased visibility for physicians.
AtriCure, Inc.（ATRC）是心房顫動（Afib）、左房耳緣（LAA）管理和術後疼痛管理手術治療和療法的領先創新者，今天宣佈利用新獲得510(k)準備的AtriClip FLEX-Mini設備治療了第一名患者。AtriClip FLEX-Mini作爲市場上最小型的外科LAA設備設立了一個新的標準，並藉助AtriCure的AtriClip平台的成熟技術，提供了增強的醫療人員使用便捷性和設計簡單性，從而提供了增強的使用便捷性和提高了醫生的可見性。
譯文內容由第三人軟體翻譯。